Brandl, Carolin <br/><br/>
B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.  [electronic resource] 

 -  PloS one  May 2010 
 - e10800 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0010800  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD1d--immunology<br/>Antigens, Surface--metabolism<br/>Apoptosis Regulatory Proteins--metabolism<br/>B7-1 Antigen--metabolism<br/>B7-H1 Antigen<br/>Biomarkers--metabolism<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Cell Line<br/>Cell Membrane--drug effects<br/>Central Nervous System--drug effects<br/>Dendritic Cells--drug effects<br/>Encephalomyelitis, Autoimmune, Experimental--immunology<br/>Epitopes--immunology<br/>Lymphocyte Activation--drug effects<br/>Membrane Glycoproteins--deficiency<br/>Mice<br/>Natural Killer T-Cells--drug effects<br/>Organic Chemicals--immunology<br/>Peptides--deficiency<br/>Programmed Cell Death 1 Receptor<br/>Tumor Necrosis Factor-alpha--administration & dosage